ZA200403711B - Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same. - Google Patents
Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same. Download PDFInfo
- Publication number
- ZA200403711B ZA200403711B ZA200403711A ZA200403711A ZA200403711B ZA 200403711 B ZA200403711 B ZA 200403711B ZA 200403711 A ZA200403711 A ZA 200403711A ZA 200403711 A ZA200403711 A ZA 200403711A ZA 200403711 B ZA200403711 B ZA 200403711B
- Authority
- ZA
- South Africa
- Prior art keywords
- methyl
- tetrahydro
- dichloro
- isoquinolin
- phenyl
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims description 21
- OSZMNJRKIPAVOS-UHFFFAOYSA-N 4-phenyl-1,2,3,4-tetrahydroisoquinoline Chemical class C1NCC2=CC=CC=C2C1C1=CC=CC=C1 OSZMNJRKIPAVOS-UHFFFAOYSA-N 0.000 title claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 212
- 125000001153 fluoro group Chemical group F* 0.000 claims description 211
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 77
- -1 N,N-dimethylaminoethyl Chemical group 0.000 claims description 73
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 40
- 229910052739 hydrogen Inorganic materials 0.000 claims description 38
- 229910052760 oxygen Inorganic materials 0.000 claims description 38
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 32
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 32
- 150000001875 compounds Chemical class 0.000 claims description 30
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 24
- 125000001424 substituent group Chemical group 0.000 claims description 22
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 20
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 19
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 19
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 claims description 16
- 229910004727 OSO3H Inorganic materials 0.000 claims description 16
- 229910006069 SO3H Inorganic materials 0.000 claims description 16
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 claims description 16
- 150000003839 salts Chemical class 0.000 claims description 14
- 229910052799 carbon Inorganic materials 0.000 claims description 13
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims description 11
- 125000002883 imidazolyl group Chemical group 0.000 claims description 11
- 125000006203 morpholinoethyl group Chemical group [H]C([H])(*)C([H])([H])N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H] 0.000 claims description 11
- 229910052757 nitrogen Inorganic materials 0.000 claims description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 11
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 11
- 125000002971 oxazolyl group Chemical group 0.000 claims description 11
- 125000003386 piperidinyl group Chemical group 0.000 claims description 11
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 11
- 125000004076 pyridyl group Chemical group 0.000 claims description 11
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 11
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 11
- 125000000335 thiazolyl group Chemical group 0.000 claims description 11
- 125000001425 triazolyl group Chemical group 0.000 claims description 11
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 10
- 229940080818 propionamide Drugs 0.000 claims description 9
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical class OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 8
- 150000003254 radicals Chemical class 0.000 claims description 8
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 6
- 101150020251 NR13 gene Proteins 0.000 claims description 6
- 125000001072 heteroaryl group Chemical group 0.000 claims description 6
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 6
- AJSBYWKHOANAIZ-UHFFFAOYSA-N 1-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-methylurea Chemical compound CNC(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 AJSBYWKHOANAIZ-UHFFFAOYSA-N 0.000 claims description 5
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 5
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims description 5
- YPEQXVPZMTVGCT-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]acetamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(NC(C)=O)=C1 YPEQXVPZMTVGCT-UHFFFAOYSA-N 0.000 claims description 5
- WWMLHLXNNOJHCI-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]morpholine-4-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)N1CCOCC1 WWMLHLXNNOJHCI-UHFFFAOYSA-N 0.000 claims description 5
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims description 5
- FPRVCASHSFEVJD-UHFFFAOYSA-N 1-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-ethylurea Chemical compound CCNC(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 FPRVCASHSFEVJD-UHFFFAOYSA-N 0.000 claims description 4
- JVZKSFQFKWZPOW-UHFFFAOYSA-N 1-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-ethylurea Chemical compound C1=CC(NC(=O)NCC)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 JVZKSFQFKWZPOW-UHFFFAOYSA-N 0.000 claims description 4
- JYHUZKWGHVORTI-UHFFFAOYSA-N 1-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-methylthiourea Chemical compound C1=CC(NC(=S)NC)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 JYHUZKWGHVORTI-UHFFFAOYSA-N 0.000 claims description 4
- APTIOEQOZBJPFQ-UHFFFAOYSA-N 1-acetyl-n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]piperidine-4-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)C1CCN(C(C)=O)CC1 APTIOEQOZBJPFQ-UHFFFAOYSA-N 0.000 claims description 4
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 claims description 4
- UNNPAFDYRLETBW-UHFFFAOYSA-N 3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)benzenesulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(N)(=O)=O)=C1 UNNPAFDYRLETBW-UHFFFAOYSA-N 0.000 claims description 4
- UAQVNFADDKMTMC-UHFFFAOYSA-N 4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)-n-[2-(dimethylamino)ethyl]benzamide Chemical compound C1=CC(C(=O)NCCN(C)C)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 UAQVNFADDKMTMC-UHFFFAOYSA-N 0.000 claims description 4
- CTKAYSOAVWUWKF-UHFFFAOYSA-N 4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)-n-ethylbenzamide Chemical compound C1=CC(C(=O)NCC)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 CTKAYSOAVWUWKF-UHFFFAOYSA-N 0.000 claims description 4
- QETVYTNAHZLDNS-UHFFFAOYSA-N 4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)benzenesulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(S(N)(=O)=O)C=C1 QETVYTNAHZLDNS-UHFFFAOYSA-N 0.000 claims description 4
- OOPDWMLXBWNOLH-UHFFFAOYSA-N 4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)benzoic acid Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(C(O)=O)C=C1 OOPDWMLXBWNOLH-UHFFFAOYSA-N 0.000 claims description 4
- JTXNWYHSDXNOAG-UHFFFAOYSA-N 4-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]morpholine Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1N1CCOCC1 JTXNWYHSDXNOAG-UHFFFAOYSA-N 0.000 claims description 4
- ZPXGMXNPRXENML-UHFFFAOYSA-N 5-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)-2-hydroxybenzoic acid Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(O)C(C(O)=O)=C1 ZPXGMXNPRXENML-UHFFFAOYSA-N 0.000 claims description 4
- WFKAJVHLWXSISD-UHFFFAOYSA-N anhydrous dimethyl-acetamide Natural products CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 claims description 4
- 229940047889 isobutyramide Drugs 0.000 claims description 4
- 125000004434 sulfur atom Chemical group 0.000 claims description 4
- XSTRCKXRNHVVTA-UHFFFAOYSA-N 1-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-[2-(dimethylamino)ethyl]urea Chemical compound CN(C)CCNC(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 XSTRCKXRNHVVTA-UHFFFAOYSA-N 0.000 claims description 3
- ITHVMVOSCQULAU-UHFFFAOYSA-N 1-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-ethylthiourea Chemical compound CCNC(=S)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 ITHVMVOSCQULAU-UHFFFAOYSA-N 0.000 claims description 3
- NHJXZSFGEZQCQW-UHFFFAOYSA-N 1-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-propylurea Chemical compound C1=CC(NC(=O)NCCC)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 NHJXZSFGEZQCQW-UHFFFAOYSA-N 0.000 claims description 3
- LNBXSRHKTFMPBN-UHFFFAOYSA-N 2,6-diamino-n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]hexanamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(NC(=O)C(N)CCCCN)C=C1 LNBXSRHKTFMPBN-UHFFFAOYSA-N 0.000 claims description 3
- XMYPFIYRTAOIFI-UHFFFAOYSA-N 2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)aniline Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC=C1N XMYPFIYRTAOIFI-UHFFFAOYSA-N 0.000 claims description 3
- FXDGSBKQIDBHPQ-UHFFFAOYSA-N 2-amino-n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]butanamide Chemical compound CCC(N)C(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 FXDGSBKQIDBHPQ-UHFFFAOYSA-N 0.000 claims description 3
- ZNIDKPZEMMUEAU-UHFFFAOYSA-N 2-amino-n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]propanamide Chemical compound CC(N)C(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 ZNIDKPZEMMUEAU-UHFFFAOYSA-N 0.000 claims description 3
- HWHOOFAFSRSPOT-UHFFFAOYSA-N 2-chloro-5-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)benzenesulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(Cl)C(S(N)(=O)=O)=C1 HWHOOFAFSRSPOT-UHFFFAOYSA-N 0.000 claims description 3
- KMZLUIVXQDYDEM-UHFFFAOYSA-N 2-methyl-4-phenyl-6,8-bis(trifluoromethyl)-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC(C(F)(F)F)=CC(C(F)(F)F)=C2CN(C)CC1C1=CC=CC=C1 KMZLUIVXQDYDEM-UHFFFAOYSA-N 0.000 claims description 3
- VKMIFAXQPZVCKG-UHFFFAOYSA-N 3-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1,1-diethylurea Chemical compound CCN(CC)C(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 VKMIFAXQPZVCKG-UHFFFAOYSA-N 0.000 claims description 3
- OPKTYGMCIDQTHP-UHFFFAOYSA-N 4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)-n-propylbenzamide Chemical compound C1=CC(C(=O)NCCC)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 OPKTYGMCIDQTHP-UHFFFAOYSA-N 0.000 claims description 3
- ATZPMMXKZFAFOP-UHFFFAOYSA-N 4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)aniline Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(N)C=C1 ATZPMMXKZFAFOP-UHFFFAOYSA-N 0.000 claims description 3
- JWYJULAOMWNOJL-UHFFFAOYSA-N 4-[3-[bis(methylamino)sulfamoylamino]phenyl]-6,8-dichloro-2-methyl-3,4-dihydro-1H-isoquinoline Chemical compound CNN(NC)S(=O)(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 JWYJULAOMWNOJL-UHFFFAOYSA-N 0.000 claims description 3
- PSOOVXSNQHEDMM-UHFFFAOYSA-N 5-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)-2-hydroxy-n-methylbenzamide Chemical compound C1=C(O)C(C(=O)NC)=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 PSOOVXSNQHEDMM-UHFFFAOYSA-N 0.000 claims description 3
- CLZQZTZRISZXAP-UHFFFAOYSA-N 5-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)-n-[2-(dimethylamino)ethyl]-2-hydroxybenzamide Chemical compound C1=C(O)C(C(=O)NCCN(C)C)=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 CLZQZTZRISZXAP-UHFFFAOYSA-N 0.000 claims description 3
- AMVYEVIRFWDRSX-UHFFFAOYSA-N 5-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)-n-ethyl-2-hydroxybenzamide Chemical compound C1=C(O)C(C(=O)NCC)=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 AMVYEVIRFWDRSX-UHFFFAOYSA-N 0.000 claims description 3
- LAXMGXGWGIBHHT-UHFFFAOYSA-N 6,8-dichloro-2-methyl-4-(4-piperidin-1-ylphenyl)-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1N1CCCCC1 LAXMGXGWGIBHHT-UHFFFAOYSA-N 0.000 claims description 3
- LEHSIQYEMSWARG-UHFFFAOYSA-N n-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]methanesulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC=C1NS(C)(=O)=O LEHSIQYEMSWARG-UHFFFAOYSA-N 0.000 claims description 3
- LRYLUJZAQSAIMW-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1,1,1-trifluoromethanesulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(NS(=O)(=O)C(F)(F)F)=C1 LRYLUJZAQSAIMW-UHFFFAOYSA-N 0.000 claims description 3
- VHPNMMFTCKVPQW-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1,4-dimethylpyrrole-2-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)C1=CC(C)=CN1C VHPNMMFTCKVPQW-UHFFFAOYSA-N 0.000 claims description 3
- AWDVARDJXPUYRE-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1-methylsulfonylpiperidine-4-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)C1CCN(S(C)(=O)=O)CC1 AWDVARDJXPUYRE-UHFFFAOYSA-N 0.000 claims description 3
- UOWFCRXLHWYKTE-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-2,2-dimethylpropanamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(NC(=O)C(C)(C)C)=C1 UOWFCRXLHWYKTE-UHFFFAOYSA-N 0.000 claims description 3
- ZBTGHYLYYMVAEV-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-4-nitro-1h-pyrrole-2-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)C1=CC([N+]([O-])=O)=CN1 ZBTGHYLYYMVAEV-UHFFFAOYSA-N 0.000 claims description 3
- HXYSUBQOVFAWTM-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]propanamide Chemical compound CCC(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 HXYSUBQOVFAWTM-UHFFFAOYSA-N 0.000 claims description 3
- MTFHARGXDVSDNK-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1,2-dimethylimidazole-4-sulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NS(=O)(=O)C1=CN(C)C(C)=N1 MTFHARGXDVSDNK-UHFFFAOYSA-N 0.000 claims description 3
- MFOCFIBNNDJEAI-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1-methylpiperidine-4-carboxamide Chemical compound C1CN(C)CCC1C(=O)NC1=CC=C(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)C=C1 MFOCFIBNNDJEAI-UHFFFAOYSA-N 0.000 claims description 3
- WSBDGRSGRDDLAL-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1-methylsulfonylpiperidine-4-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)C1CCN(S(C)(=O)=O)CC1 WSBDGRSGRDDLAL-UHFFFAOYSA-N 0.000 claims description 3
- XOLKVTDSPGGFNP-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1h-pyrrole-2-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)C1=CC=CN1 XOLKVTDSPGGFNP-UHFFFAOYSA-N 0.000 claims description 3
- KVKHCCXAFAEQAA-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-2,2-dimethylpropanamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(NC(=O)C(C)(C)C)C=C1 KVKHCCXAFAEQAA-UHFFFAOYSA-N 0.000 claims description 3
- GIBGLOZYQRRBPY-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-2-methylpropanamide Chemical compound C1=CC(NC(=O)C(C)C)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 GIBGLOZYQRRBPY-UHFFFAOYSA-N 0.000 claims description 3
- CJKOAUWXSZLXLP-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-4-nitro-1h-pyrrole-2-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)C1=CC([N+]([O-])=O)=CN1 CJKOAUWXSZLXLP-UHFFFAOYSA-N 0.000 claims description 3
- CUMPRBLVHDOHMH-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]ethanesulfonamide Chemical compound C1=CC(NS(=O)(=O)CC)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 CUMPRBLVHDOHMH-UHFFFAOYSA-N 0.000 claims description 3
- MYHYDYGXHXLBPC-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]propanamide Chemical compound C1=CC(NC(=O)CC)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 MYHYDYGXHXLBPC-UHFFFAOYSA-N 0.000 claims description 3
- VRKKCPDOYHNJPJ-UHFFFAOYSA-N n-[4-(6-bromo-8-chloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]acetamide Chemical compound C12=CC(Br)=CC(Cl)=C2CN(C)CC1C1=CC=C(NC(C)=O)C=C1 VRKKCPDOYHNJPJ-UHFFFAOYSA-N 0.000 claims description 3
- WBWCTXNRXFMBNU-UHFFFAOYSA-N n-[5-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfamoyl]-4-methyl-1,3-thiazol-2-yl]acetamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NS(=O)(=O)C=1SC(NC(C)=O)=NC=1C WBWCTXNRXFMBNU-UHFFFAOYSA-N 0.000 claims description 3
- MQLSXMWPISYYKX-UHFFFAOYSA-N n-[5-[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfamoyl]-4-methyl-1,3-thiazol-2-yl]acetamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NS(=O)(=O)C=1SC(NC(C)=O)=NC=1C MQLSXMWPISYYKX-UHFFFAOYSA-N 0.000 claims description 3
- 229960003966 nicotinamide Drugs 0.000 claims description 3
- 235000005152 nicotinamide Nutrition 0.000 claims description 3
- 239000011570 nicotinamide Substances 0.000 claims description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 125000006413 ring segment Chemical group 0.000 claims description 3
- 239000004576 sand Substances 0.000 claims description 3
- 125000001544 thienyl group Chemical group 0.000 claims description 3
- RYIFNGJHJNBKTM-UHFFFAOYSA-N 2-amino-n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]butanamide Chemical compound C1=CC(NC(=O)C(N)CC)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 RYIFNGJHJNBKTM-UHFFFAOYSA-N 0.000 claims description 2
- MUBZVQSJVOVBRY-UHFFFAOYSA-N 4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)-n,n-dimethylbenzenesulfonamide Chemical compound C1=CC(S(=O)(=O)N(C)C)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 MUBZVQSJVOVBRY-UHFFFAOYSA-N 0.000 claims description 2
- YCHHDVUJLGIJPF-UHFFFAOYSA-N 5-bromo-n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]thiophene-2-sulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NS(=O)(=O)C1=CC=C(Br)S1 YCHHDVUJLGIJPF-UHFFFAOYSA-N 0.000 claims description 2
- LLBFSDJSRJVGTP-UHFFFAOYSA-N 5-chloro-n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1,3-dimethylpyrazole-4-sulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NS(=O)(=O)C=1C(C)=NN(C)C=1Cl LLBFSDJSRJVGTP-UHFFFAOYSA-N 0.000 claims description 2
- UCWLCWOJRHFLRB-UHFFFAOYSA-N 6,8-dichloro-2-methyl-4-[4-(4-methylpiperazin-1-yl)phenyl]-3,4-dihydro-1h-isoquinoline Chemical compound C1CN(C)CCN1C1=CC=C(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)C=C1 UCWLCWOJRHFLRB-UHFFFAOYSA-N 0.000 claims description 2
- GODVYEGZXKHRSC-UHFFFAOYSA-N n-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-2,2-dimethylpropanamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC=C1NC(=O)C(C)(C)C GODVYEGZXKHRSC-UHFFFAOYSA-N 0.000 claims description 2
- PLZMVWQZERWXKS-UHFFFAOYSA-N n-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]cyclopentanecarboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC=C1NC(=O)C1CCCC1 PLZMVWQZERWXKS-UHFFFAOYSA-N 0.000 claims description 2
- XHAYFWQFNQJNPB-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-2,2,2-trifluoroacetamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(NC(=O)C(F)(F)F)=C1 XHAYFWQFNQJNPB-UHFFFAOYSA-N 0.000 claims description 2
- UMCNOZBTMSEEFG-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-2-methylpropanamide Chemical compound CC(C)C(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 UMCNOZBTMSEEFG-UHFFFAOYSA-N 0.000 claims description 2
- KFHHWUSTHZTJJO-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-4-methylpiperazine-1-carboxamide Chemical compound C1CN(C)CCN1C(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 KFHHWUSTHZTJJO-UHFFFAOYSA-N 0.000 claims description 2
- GSYJEACXZYNBJV-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]cyclobutanecarboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)C1CCC1 GSYJEACXZYNBJV-UHFFFAOYSA-N 0.000 claims description 2
- YHMADQVUGPYHDA-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]cyclopropanecarboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)C1CC1 YHMADQVUGPYHDA-UHFFFAOYSA-N 0.000 claims description 2
- FTLIDAYDHCTRSY-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]pentanamide Chemical compound CCCCC(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 FTLIDAYDHCTRSY-UHFFFAOYSA-N 0.000 claims description 2
- ZTVNCRHIUNTHFV-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]piperidine-1-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)N1CCCCC1 ZTVNCRHIUNTHFV-UHFFFAOYSA-N 0.000 claims description 2
- PNQMLDNLGOMHTQ-UHFFFAOYSA-N n-[4-(2,6,8-trimethyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]acetamide Chemical compound C12=CC(C)=CC(C)=C2CN(C)CC1C1=CC=C(NC(C)=O)C=C1 PNQMLDNLGOMHTQ-UHFFFAOYSA-N 0.000 claims description 2
- UNYCACXKYQUMSY-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1h-pyrazole-4-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)C=1C=NNC=1 UNYCACXKYQUMSY-UHFFFAOYSA-N 0.000 claims description 2
- AFYSJMWYNWPKSL-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-2,2,2-trifluoroacetamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(NC(=O)C(F)(F)F)C=C1 AFYSJMWYNWPKSL-UHFFFAOYSA-N 0.000 claims description 2
- ZALUHMPZFDKMJO-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-2-(methylamino)acetamide Chemical compound C1=CC(NC(=O)CNC)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 ZALUHMPZFDKMJO-UHFFFAOYSA-N 0.000 claims description 2
- NNFURQSXBLBVIX-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]cyclopropanecarboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)C1CC1 NNFURQSXBLBVIX-UHFFFAOYSA-N 0.000 claims description 2
- NFSUQUVCYAHAMO-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]pentanamide Chemical compound C1=CC(NC(=O)CCCC)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 NFSUQUVCYAHAMO-UHFFFAOYSA-N 0.000 claims description 2
- GHXYNEAEGIOJED-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)C1CCCN1 GHXYNEAEGIOJED-UHFFFAOYSA-N 0.000 claims description 2
- VQAASMPOUCKYBN-UHFFFAOYSA-N n-[4-(8-chloro-2-methyl-6-morpholin-4-yl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]acetamide Chemical compound C12=CC(N3CCOCC3)=CC(Cl)=C2CN(C)CC1C1=CC=C(NC(C)=O)C=C1 VQAASMPOUCKYBN-UHFFFAOYSA-N 0.000 claims description 2
- OSBUINWGQXMTBW-UHFFFAOYSA-N n-[4-[8-chloro-2-methyl-6-(4-methylpiperazin-1-yl)-3,4-dihydro-1h-isoquinolin-4-yl]phenyl]acetamide Chemical compound C1CN(C)CCN1C1=CC(Cl)=C(CN(C)CC2C=3C=CC(NC(C)=O)=CC=3)C2=C1 OSBUINWGQXMTBW-UHFFFAOYSA-N 0.000 claims description 2
- 238000011282 treatment Methods 0.000 claims 13
- 239000004202 carbamide Substances 0.000 claims 10
- 238000011321 prophylaxis Methods 0.000 claims 10
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 208000035475 disorder Diseases 0.000 claims 6
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 5
- ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Substances NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims 5
- JUMVJHLZDVSQPC-UHFFFAOYSA-N 1-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-(2-methoxyethyl)urea Chemical compound COCCNC(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 JUMVJHLZDVSQPC-UHFFFAOYSA-N 0.000 claims 4
- BQKRJALYXOHITF-UHFFFAOYSA-N 1-acetyl-n-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]piperidine-4-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC=C1NC(=O)C1CCN(C(C)=O)CC1 BQKRJALYXOHITF-UHFFFAOYSA-N 0.000 claims 4
- 125000004429 atom Chemical group 0.000 claims 4
- GTMHPRFXOPJRAN-UHFFFAOYSA-N methyl n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]carbamate Chemical compound COC(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 GTMHPRFXOPJRAN-UHFFFAOYSA-N 0.000 claims 4
- NGXLFMIEWOPOCG-UHFFFAOYSA-N n-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-4-methylpiperazine-1-carboxamide Chemical compound C1CN(C)CCN1C(=O)NC1=CC=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 NGXLFMIEWOPOCG-UHFFFAOYSA-N 0.000 claims 4
- DVRWATLEBPGVKE-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]ethanesulfonamide Chemical compound CCS(=O)(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 DVRWATLEBPGVKE-UHFFFAOYSA-N 0.000 claims 4
- FXKXMRNGDQZZGG-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]pyridine-3-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)C1=CC=CN=C1 FXKXMRNGDQZZGG-UHFFFAOYSA-N 0.000 claims 4
- IHUHNFCQYFDEQN-UHFFFAOYSA-N 1-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-methylurea Chemical compound CNC(=O)NC1=CC=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 IHUHNFCQYFDEQN-UHFFFAOYSA-N 0.000 claims 3
- FCRMNRJYJUXJQD-UHFFFAOYSA-N 1-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1,3-dimethylurea Chemical compound CNC(=O)N(C)C1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 FCRMNRJYJUXJQD-UHFFFAOYSA-N 0.000 claims 3
- AQZRISWBYMCHSD-UHFFFAOYSA-N 1-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-(2-hydroxyethyl)urea Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(NC(=O)NCCO)=C1 AQZRISWBYMCHSD-UHFFFAOYSA-N 0.000 claims 3
- BURDAEWYGHBUPJ-UHFFFAOYSA-N 1-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-pyridin-3-ylurea Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)NC1=CC=CN=C1 BURDAEWYGHBUPJ-UHFFFAOYSA-N 0.000 claims 3
- PLIDHZDTMLRUOJ-UHFFFAOYSA-N 1-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-methylurea Chemical compound C1=CC(NC(=O)NC)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 PLIDHZDTMLRUOJ-UHFFFAOYSA-N 0.000 claims 3
- PAEROSAVFNDZFE-UHFFFAOYSA-N 1-acetyl-n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]piperidine-4-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)C1CCN(C(C)=O)CC1 PAEROSAVFNDZFE-UHFFFAOYSA-N 0.000 claims 3
- ITSVCLWKVUKMHH-UHFFFAOYSA-N 3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)aniline Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(N)=C1 ITSVCLWKVUKMHH-UHFFFAOYSA-N 0.000 claims 3
- ROCHTQWNNZUYOK-UHFFFAOYSA-N 3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)benzoic acid Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(C(O)=O)=C1 ROCHTQWNNZUYOK-UHFFFAOYSA-N 0.000 claims 3
- DHCPVRCXJZCKNO-UHFFFAOYSA-N 3-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1-methyl-1-(1-methylpiperidin-4-yl)urea Chemical compound C=1C=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=CC=1NC(=O)N(C)C1CCN(C)CC1 DHCPVRCXJZCKNO-UHFFFAOYSA-N 0.000 claims 3
- OGVXGNOUQNLCAU-UHFFFAOYSA-N 4-(4-bromophenyl)-6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(Br)C=C1 OGVXGNOUQNLCAU-UHFFFAOYSA-N 0.000 claims 3
- WOSRCHOJUSCXJV-UHFFFAOYSA-N 6,8-dichloro-2-cyclopropyl-4-phenyl-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C2CC2)CC1C1=CC=CC=C1 WOSRCHOJUSCXJV-UHFFFAOYSA-N 0.000 claims 3
- SHYIEDSDUINFSE-UHFFFAOYSA-N ethyl 3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)benzoate Chemical compound CCOC(=O)C1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 SHYIEDSDUINFSE-UHFFFAOYSA-N 0.000 claims 3
- OXXMOPMKTUUZKA-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1,2-dimethylimidazole-4-sulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NS(=O)(=O)C1=CN(C)C(C)=N1 OXXMOPMKTUUZKA-UHFFFAOYSA-N 0.000 claims 3
- VTACXQBZRPNVPL-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-2-(methylamino)acetamide Chemical compound CNCC(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 VTACXQBZRPNVPL-UHFFFAOYSA-N 0.000 claims 3
- DYDSZGXXNHKNSY-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]butanamide Chemical compound CCCC(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 DYDSZGXXNHKNSY-UHFFFAOYSA-N 0.000 claims 3
- FAGXKVFWEQSXPT-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]pyrrolidine-1-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)N1CCCC1 FAGXKVFWEQSXPT-UHFFFAOYSA-N 0.000 claims 3
- KNIROMQEWJVMTR-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]acetamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(NC(C)=O)C=C1 KNIROMQEWJVMTR-UHFFFAOYSA-N 0.000 claims 3
- RXJOGSUJFYNTKI-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]methanesulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(NS(C)(=O)=O)C=C1 RXJOGSUJFYNTKI-UHFFFAOYSA-N 0.000 claims 3
- QTYREFWMNGDGFM-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]morpholine-4-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)N1CCOCC1 QTYREFWMNGDGFM-UHFFFAOYSA-N 0.000 claims 3
- RTEVZCUIXXCDNH-HNNXBMFYSA-N 1-[2-[(4r)-6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl]phenyl]-3-ethylurea Chemical compound CCNC(=O)NC1=CC=CC=C1[C@H]1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 RTEVZCUIXXCDNH-HNNXBMFYSA-N 0.000 claims 2
- RTEVZCUIXXCDNH-OAHLLOKOSA-N 1-[2-[(4s)-6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl]phenyl]-3-ethylurea Chemical compound CCNC(=O)NC1=CC=CC=C1[C@@H]1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 RTEVZCUIXXCDNH-OAHLLOKOSA-N 0.000 claims 2
- VMKGDZFHKYKODW-UHFFFAOYSA-N 1-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-(oxolan-3-yl)urea Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)NC1CCOC1 VMKGDZFHKYKODW-UHFFFAOYSA-N 0.000 claims 2
- NTCGIGAQCJVDSF-UHFFFAOYSA-N 1-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-[2-(dimethylamino)ethyl]-1-methylurea Chemical compound CN(C)CCNC(=O)N(C)C1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 NTCGIGAQCJVDSF-UHFFFAOYSA-N 0.000 claims 2
- CABPEGUVUDDIPO-UHFFFAOYSA-N 1-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-[3-(dimethylamino)propyl]urea Chemical compound CN(C)CCCNC(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 CABPEGUVUDDIPO-UHFFFAOYSA-N 0.000 claims 2
- MWYUQZBQIATMOS-UHFFFAOYSA-N 1-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-pyridin-4-ylurea Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)NC1=CC=NC=C1 MWYUQZBQIATMOS-UHFFFAOYSA-N 0.000 claims 2
- PVBFEYGNAZZZGL-UHFFFAOYSA-N 1-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-[2-(dimethylamino)ethyl]urea Chemical compound C1=CC(NC(=O)NCCN(C)C)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 PVBFEYGNAZZZGL-UHFFFAOYSA-N 0.000 claims 2
- GUCMMJZKXNYAJI-UHFFFAOYSA-N 2,2-dimethylpropyl n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]carbamate Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(NC(=O)OCC(C)(C)C)C=C1 GUCMMJZKXNYAJI-UHFFFAOYSA-N 0.000 claims 2
- DGHLDWUCDWSFFO-UHFFFAOYSA-N 2,6-diamino-n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]hexanamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(NC(=O)C(N)CCCCN)=C1 DGHLDWUCDWSFFO-UHFFFAOYSA-N 0.000 claims 2
- IEDADLUPTJVCQY-UHFFFAOYSA-N 2-(dimethylamino)ethyl n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]carbamate Chemical compound C1=CC(NC(=O)OCCN(C)C)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 IEDADLUPTJVCQY-UHFFFAOYSA-N 0.000 claims 2
- RQQCHDXBJHQNJL-UHFFFAOYSA-N 3-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1,1-diethylurea Chemical compound CCN(CC)C(=O)NC1=CC=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 RQQCHDXBJHQNJL-UHFFFAOYSA-N 0.000 claims 2
- KERASNBQJINFCX-UHFFFAOYSA-N 3-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1,1-dimethylurea Chemical compound CN(C)C(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 KERASNBQJINFCX-UHFFFAOYSA-N 0.000 claims 2
- AUAJGSVTHSQDDD-UHFFFAOYSA-N 3-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1-[2-(dimethylamino)ethyl]-1-methylurea Chemical compound CN(C)CCN(C)C(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 AUAJGSVTHSQDDD-UHFFFAOYSA-N 0.000 claims 2
- SRGVHVFTRQXGGN-UHFFFAOYSA-N 3-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1-[3-(dimethylamino)propyl]-1-methylurea Chemical compound CN(C)CCCN(C)C(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 SRGVHVFTRQXGGN-UHFFFAOYSA-N 0.000 claims 2
- GEIJIORDDUTTNH-UHFFFAOYSA-N 3-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1,1-diethylurea Chemical compound C1=CC(NC(=O)N(CC)CC)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 GEIJIORDDUTTNH-UHFFFAOYSA-N 0.000 claims 2
- UJQNTOIYAZPWLI-UHFFFAOYSA-N 4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)-n-methylaniline Chemical compound C1=CC(NC)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 UJQNTOIYAZPWLI-UHFFFAOYSA-N 0.000 claims 2
- XUPRYVJPMQCECW-UHFFFAOYSA-N 4-[4-[bis(methylamino)sulfamoylamino]phenyl]-6,8-dichloro-2-methyl-3,4-dihydro-1H-isoquinoline Chemical compound C1=CC(NS(=O)(=O)N(NC)NC)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 XUPRYVJPMQCECW-UHFFFAOYSA-N 0.000 claims 2
- BYEHLECXGQISFM-UHFFFAOYSA-N 6,8-dichloro-2-methyl-4-(4-pyrrolidin-1-ylphenyl)-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1N1CCCC1 BYEHLECXGQISFM-UHFFFAOYSA-N 0.000 claims 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 2
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 claims 2
- WZFGYXOOIXKUTM-UHFFFAOYSA-N ethyl n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]carbamate Chemical compound CCOC(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 WZFGYXOOIXKUTM-UHFFFAOYSA-N 0.000 claims 2
- 230000000302 ischemic effect Effects 0.000 claims 2
- STCWGDDBTDIQQN-UHFFFAOYSA-N methyl n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]carbamate Chemical compound C1=CC(NC(=O)OC)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 STCWGDDBTDIQQN-UHFFFAOYSA-N 0.000 claims 2
- LAWJEGWAJSUTSI-UHFFFAOYSA-N n-(diaminomethylidene)-5-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)-2-hydroxybenzamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(O)C(C(=O)NC(N)=N)=C1 LAWJEGWAJSUTSI-UHFFFAOYSA-N 0.000 claims 2
- DJPFXNUZCUMRGR-UHFFFAOYSA-N n-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-2-methylpropanamide Chemical compound CC(C)C(=O)NC1=CC=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 DJPFXNUZCUMRGR-UHFFFAOYSA-N 0.000 claims 2
- OFNLRZXVBDQSJB-UHFFFAOYSA-N n-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]cyclobutanecarboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC=C1NC(=O)C1CCC1 OFNLRZXVBDQSJB-UHFFFAOYSA-N 0.000 claims 2
- XMXDMJXSPHBYFN-UHFFFAOYSA-N n-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]ethanesulfonamide Chemical compound CCS(=O)(=O)NC1=CC=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 XMXDMJXSPHBYFN-UHFFFAOYSA-N 0.000 claims 2
- FCUHTHRZFJNSIJ-UHFFFAOYSA-N n-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]pentanamide Chemical compound CCCCC(=O)NC1=CC=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 FCUHTHRZFJNSIJ-UHFFFAOYSA-N 0.000 claims 2
- GKMFOKLSWWWHIM-UHFFFAOYSA-N n-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]propanamide Chemical compound CCC(=O)NC1=CC=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 GKMFOKLSWWWHIM-UHFFFAOYSA-N 0.000 claims 2
- QUQLGXZSZHEERG-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-2-(dimethylamino)acetamide Chemical compound CN(C)CC(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 QUQLGXZSZHEERG-UHFFFAOYSA-N 0.000 claims 2
- TXPWACDQMYDSSV-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3,5-dimethyl-1h-pyrazole-4-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)C=1C(C)=NNC=1C TXPWACDQMYDSSV-UHFFFAOYSA-N 0.000 claims 2
- UQTMMQOPRHKGPO-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-5-(trifluoromethyl)-1h-pyrazole-4-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)C1=CNN=C1C(F)(F)F UQTMMQOPRHKGPO-UHFFFAOYSA-N 0.000 claims 2
- NCKFDAVBILKBOL-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]pyridine-4-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)C1=CC=NC=C1 NCKFDAVBILKBOL-UHFFFAOYSA-N 0.000 claims 2
- DPQHWDSAFGLDQW-OAHLLOKOSA-N n-[3-[(4r)-6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl]phenyl]methanesulfonamide Chemical compound C1([C@H]2CN(CC3=C(Cl)C=C(Cl)C=C32)C)=CC=CC(NS(C)(=O)=O)=C1 DPQHWDSAFGLDQW-OAHLLOKOSA-N 0.000 claims 2
- DPQHWDSAFGLDQW-HNNXBMFYSA-N n-[3-[(4s)-6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl]phenyl]methanesulfonamide Chemical compound C1([C@@H]2CN(CC3=C(Cl)C=C(Cl)C=C32)C)=CC=CC(NS(C)(=O)=O)=C1 DPQHWDSAFGLDQW-HNNXBMFYSA-N 0.000 claims 2
- YJJYOXKGZDPJNQ-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1,4-dimethylpyrrole-2-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)C1=CC(C)=CN1C YJJYOXKGZDPJNQ-UHFFFAOYSA-N 0.000 claims 2
- GDEREPIFEAQWAJ-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1h-imidazole-5-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)C1=CNC=N1 GDEREPIFEAQWAJ-UHFFFAOYSA-N 0.000 claims 2
- MGZJRLQDQAFUML-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1h-pyrrole-3-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)C=1C=CNC=1 MGZJRLQDQAFUML-UHFFFAOYSA-N 0.000 claims 2
- ROPYLDOXCQAVQA-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-2-methylpiperidine-1-carboxamide Chemical compound CC1CCCCN1C(=O)NC1=CC=C(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)C=C1 ROPYLDOXCQAVQA-UHFFFAOYSA-N 0.000 claims 2
- JPLOLGHBNKSCIU-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]cyclopentanecarboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)C1CCCC1 JPLOLGHBNKSCIU-UHFFFAOYSA-N 0.000 claims 2
- CNFBIEVFBXQXMZ-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]formamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(NC=O)C=C1 CNFBIEVFBXQXMZ-UHFFFAOYSA-N 0.000 claims 2
- KZFKXSUWWNLRTN-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]piperidine-1-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)N1CCCCC1 KZFKXSUWWNLRTN-UHFFFAOYSA-N 0.000 claims 2
- PCLUWFLLBNYDPM-UHFFFAOYSA-N n-[4-(8-chloro-2-methyl-6-pyrrolidin-1-yl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]acetamide Chemical compound C12=CC(N3CCCC3)=CC(Cl)=C2CN(C)CC1C1=CC=C(NC(C)=O)C=C1 PCLUWFLLBNYDPM-UHFFFAOYSA-N 0.000 claims 2
- 210000000056 organ Anatomy 0.000 claims 2
- 230000002093 peripheral effect Effects 0.000 claims 2
- MEAAMTVXPSVAPU-UHFFFAOYSA-N propan-2-yl n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]carbamate Chemical compound C1=CC(NC(=O)OC(C)C)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 MEAAMTVXPSVAPU-UHFFFAOYSA-N 0.000 claims 2
- 208000023504 respiratory system disease Diseases 0.000 claims 2
- 229940057054 1,3-dimethylurea Drugs 0.000 claims 1
- IBDGEWUCPZGMJX-UHFFFAOYSA-N 1-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-[2-(dimethylamino)ethyl]urea Chemical compound CN(C)CCNC(=O)NC1=CC=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 IBDGEWUCPZGMJX-UHFFFAOYSA-N 0.000 claims 1
- RXADDZGUSDTJLQ-UHFFFAOYSA-N 1-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-methylthiourea Chemical compound CNC(=S)NC1=CC=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 RXADDZGUSDTJLQ-UHFFFAOYSA-N 0.000 claims 1
- LZPGFPGKBJQZCX-UHFFFAOYSA-N 1-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1,3,3-trimethylurea Chemical compound CN(C)C(=O)N(C)C1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 LZPGFPGKBJQZCX-UHFFFAOYSA-N 0.000 claims 1
- AOMJDJSYZHIKEX-UHFFFAOYSA-N 1-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-(oxan-4-yl)urea Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)NC1CCOCC1 AOMJDJSYZHIKEX-UHFFFAOYSA-N 0.000 claims 1
- KSYWPYGDMGUBBP-UHFFFAOYSA-N 1-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-methylthiourea Chemical compound CNC(=S)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 KSYWPYGDMGUBBP-UHFFFAOYSA-N 0.000 claims 1
- UOWPETBXFWQVOV-UHFFFAOYSA-N 1-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1,3-dimethylurea Chemical compound C1=CC(N(C)C(=O)NC)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 UOWPETBXFWQVOV-UHFFFAOYSA-N 0.000 claims 1
- CGLKUVJBBNYBMU-UHFFFAOYSA-N 1-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3,3-diethyl-1-methylurea Chemical compound C1=CC(N(C)C(=O)N(CC)CC)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 CGLKUVJBBNYBMU-UHFFFAOYSA-N 0.000 claims 1
- AXKOUHDSAITCGZ-UHFFFAOYSA-N 1-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-[2-(dimethylamino)ethyl]-1-methylurea Chemical compound C1=CC(N(C)C(=O)NCCN(C)C)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 AXKOUHDSAITCGZ-UHFFFAOYSA-N 0.000 claims 1
- NRKYWOKHZRQRJR-UHFFFAOYSA-N 2,2,2-trifluoroacetamide Chemical compound NC(=O)C(F)(F)F NRKYWOKHZRQRJR-UHFFFAOYSA-N 0.000 claims 1
- BSVFEOVPMWUTHR-UHFFFAOYSA-N 2,2-dimethylpropyl n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]carbamate Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(NC(=O)OCC(C)(C)C)=C1 BSVFEOVPMWUTHR-UHFFFAOYSA-N 0.000 claims 1
- ZTWFDFFSPSWCEP-UHFFFAOYSA-N 2,4-dimethyl-4-phenyl-1,3-dihydroisoquinoline Chemical compound C1N(C)CC2=CC=CC=C2C1(C)C1=CC=CC=C1 ZTWFDFFSPSWCEP-UHFFFAOYSA-N 0.000 claims 1
- ZBINDVNASLJSJF-UHFFFAOYSA-N 2,6-dimethyl-4-phenyl-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC(C)=CC=C2CN(C)CC1C1=CC=CC=C1 ZBINDVNASLJSJF-UHFFFAOYSA-N 0.000 claims 1
- SUYOCKAQLJWIGF-UHFFFAOYSA-N 2,8-dimethyl-4-phenyl-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC=CC(C)=C2CN(C)CC1C1=CC=CC=C1 SUYOCKAQLJWIGF-UHFFFAOYSA-N 0.000 claims 1
- OMYVLMJTJXGABS-UHFFFAOYSA-N 2-(8-amino-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenol Chemical compound C12=CC=CC(N)=C2CN(C)CC1C1=CC=CC=C1O OMYVLMJTJXGABS-UHFFFAOYSA-N 0.000 claims 1
- DKVFCRLDRJIGRT-UHFFFAOYSA-N 2-(dimethylamino)ethyl n-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]carbamate Chemical compound CN(C)CCOC(=O)NC1=CC=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 DKVFCRLDRJIGRT-UHFFFAOYSA-N 0.000 claims 1
- DONBHZPKXHTHOG-UHFFFAOYSA-N 2-(dimethylamino)ethyl n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]carbamate Chemical compound CN(C)CCOC(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 DONBHZPKXHTHOG-UHFFFAOYSA-N 0.000 claims 1
- ZJOHLNSDKJUZFB-UHFFFAOYSA-N 2-amino-n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]acetamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(NC(=O)CN)C=C1 ZJOHLNSDKJUZFB-UHFFFAOYSA-N 0.000 claims 1
- SHOJKIYSJCEMLE-UHFFFAOYSA-N 2-amino-n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]propanamide Chemical compound C1=CC(NC(=O)C(N)C)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 SHOJKIYSJCEMLE-UHFFFAOYSA-N 0.000 claims 1
- SCROJUWBHGENKF-UHFFFAOYSA-N 2-butyl-4-phenyl-3,4-dihydro-1h-isoquinolin-8-amine Chemical compound C12=CC=CC(N)=C2CN(CCCC)CC1C1=CC=CC=C1 SCROJUWBHGENKF-UHFFFAOYSA-N 0.000 claims 1
- NNVATDBGKYTMIL-UHFFFAOYSA-N 2-methyl-4-phenyl-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC=CC=C2CN(C)CC1C1=CC=CC=C1 NNVATDBGKYTMIL-UHFFFAOYSA-N 0.000 claims 1
- ZZYPDSKOTDXNJI-UHFFFAOYSA-N 2-methyl-8-nitro-4-phenyl-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC=CC([N+]([O-])=O)=C2CN(C)CC1C1=CC=CC=C1 ZZYPDSKOTDXNJI-UHFFFAOYSA-N 0.000 claims 1
- QNFJHNLZFYNSEW-UHFFFAOYSA-N 3-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1,1-dimethylurea Chemical compound CN(C)C(=O)NC1=CC=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 QNFJHNLZFYNSEW-UHFFFAOYSA-N 0.000 claims 1
- CVIIYLIHROZSPS-UHFFFAOYSA-N 3-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1,1-dimethylurea Chemical compound C1=CC(NC(=O)N(C)C)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 CVIIYLIHROZSPS-UHFFFAOYSA-N 0.000 claims 1
- WALQZRTZISWWJK-UHFFFAOYSA-N 4-(2,4-dichlorophenyl)-2-methyl-3,4-dihydro-1h-isoquinolin-8-amine Chemical compound C12=CC=CC(N)=C2CN(C)CC1C1=CC=C(Cl)C=C1Cl WALQZRTZISWWJK-UHFFFAOYSA-N 0.000 claims 1
- YPCPHQRYILZBJY-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-2-methyl-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC=CC=C2CN(C)CC1C1=CC=C(Cl)C(Cl)=C1 YPCPHQRYILZBJY-UHFFFAOYSA-N 0.000 claims 1
- VSDQKQIGWGOUCH-UHFFFAOYSA-N 4-(3-bromophenyl)-6,8-dichloro-1-methyl-1,2,3,4-tetrahydroisoquinoline Chemical compound BrC=1C=C(C=CC=1)C1CNC(C2=C(C=C(C=C12)Cl)Cl)C VSDQKQIGWGOUCH-UHFFFAOYSA-N 0.000 claims 1
- LJCWTVCXFOSCRP-UHFFFAOYSA-N 4-(3-bromophenyl)-6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(Br)=C1 LJCWTVCXFOSCRP-UHFFFAOYSA-N 0.000 claims 1
- IWCPITVSHIVSOX-UHFFFAOYSA-N 4-(3-chlorophenyl)-2-methyl-3,4-dihydro-1h-isoquinolin-8-amine Chemical compound C12=CC=CC(N)=C2CN(C)CC1C1=CC=CC(Cl)=C1 IWCPITVSHIVSOX-UHFFFAOYSA-N 0.000 claims 1
- LMZGHKOXTNBVJV-UHFFFAOYSA-N 5,6-dichloro-2-methyl-4-phenyl-3,4-dihydro-1h-isoquinoline Chemical compound C1=CC(Cl)=C(Cl)C2=C1CN(C)CC2C1=CC=CC=C1 LMZGHKOXTNBVJV-UHFFFAOYSA-N 0.000 claims 1
- OFEGITGLTYCZKZ-UHFFFAOYSA-N 5,8-dichloro-2-methyl-4-phenyl-3,4-dihydro-1h-isoquinoline Chemical compound C12=C(Cl)C=CC(Cl)=C2CN(C)CC1C1=CC=CC=C1 OFEGITGLTYCZKZ-UHFFFAOYSA-N 0.000 claims 1
- DOGUAYAXSQVEBS-UHFFFAOYSA-N 5-(8-amino-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)-2-methoxyphenol Chemical compound C1=C(O)C(OC)=CC=C1C1C2=CC=CC(N)=C2CN(C)C1 DOGUAYAXSQVEBS-UHFFFAOYSA-N 0.000 claims 1
- MHUUTHJRVZFEKD-UHFFFAOYSA-N 5-chloro-n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1,3-dimethylpyrazole-4-sulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NS(=O)(=O)C=1C(C)=NN(C)C=1Cl MHUUTHJRVZFEKD-UHFFFAOYSA-N 0.000 claims 1
- KCAPDRPOFJFNBM-UHFFFAOYSA-N 6,7-dichloro-2-methyl-4-phenyl-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC(Cl)=C(Cl)C=C2CN(C)CC1C1=CC=CC=C1 KCAPDRPOFJFNBM-UHFFFAOYSA-N 0.000 claims 1
- HJPBWJPDZBZIBF-UHFFFAOYSA-N 6,8-dichloro-2-ethyl-4-phenyl-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(CC)CC1C1=CC=CC=C1 HJPBWJPDZBZIBF-UHFFFAOYSA-N 0.000 claims 1
- MQKVNEREAGDEFV-UHFFFAOYSA-N 6,8-dichloro-2-methyl-4-(4-methylphenyl)-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(C)C=C1 MQKVNEREAGDEFV-UHFFFAOYSA-N 0.000 claims 1
- SHBPZIGBKLSQFG-UHFFFAOYSA-N 6,8-dichloro-2-methyl-4-phenyl-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC=C1 SHBPZIGBKLSQFG-UHFFFAOYSA-N 0.000 claims 1
- LOVQZNURWACHBM-UHFFFAOYSA-N 6,8-dichloro-4-(4-chlorophenyl)-2-methyl-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(Cl)C=C1 LOVQZNURWACHBM-UHFFFAOYSA-N 0.000 claims 1
- LQKVSIAEMCZTBA-UHFFFAOYSA-N 6,8-dichloro-4-(4-fluorophenyl)-2-methyl-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(F)C=C1 LQKVSIAEMCZTBA-UHFFFAOYSA-N 0.000 claims 1
- SMNDOAOGUPEWHX-UHFFFAOYSA-N 6,8-dichloro-4-phenyl-2-propan-2-yl-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C(C)C)CC1C1=CC=CC=C1 SMNDOAOGUPEWHX-UHFFFAOYSA-N 0.000 claims 1
- MUKVGSRQTWFZKG-UHFFFAOYSA-N 6-chloro-2-methyl-4-phenyl-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC(Cl)=CC=C2CN(C)CC1C1=CC=CC=C1 MUKVGSRQTWFZKG-UHFFFAOYSA-N 0.000 claims 1
- QNWBLRHWGDFQHE-UHFFFAOYSA-N 6-methoxy-2-methyl-4-phenyl-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC(OC)=CC=C2CN(C)CC1C1=CC=CC=C1 QNWBLRHWGDFQHE-UHFFFAOYSA-N 0.000 claims 1
- FXSGMQJMMGOBJR-UHFFFAOYSA-N 7-chloro-2-methyl-4-phenyl-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC=C(Cl)C=C2CN(C)CC1C1=CC=CC=C1 FXSGMQJMMGOBJR-UHFFFAOYSA-N 0.000 claims 1
- IWTBQDAWZVFFLJ-UHFFFAOYSA-N 8-bromo-2-methyl-4-phenyl-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC=CC(Br)=C2CN(C)CC1C1=CC=CC=C1 IWTBQDAWZVFFLJ-UHFFFAOYSA-N 0.000 claims 1
- PJIBWJPNKNAWGQ-UHFFFAOYSA-N 8-chloro-2-methyl-4-phenyl-3,4-dihydro-1h-isoquinoline Chemical compound C12=CC=CC(Cl)=C2CN(C)CC1C1=CC=CC=C1 PJIBWJPNKNAWGQ-UHFFFAOYSA-N 0.000 claims 1
- OBCHZURPAABPDI-UHFFFAOYSA-N 8-methoxy-2-methyl-4-phenyl-3,4-dihydro-1h-isoquinoline Chemical compound C1N(C)CC=2C(OC)=CC=CC=2C1C1=CC=CC=C1 OBCHZURPAABPDI-UHFFFAOYSA-N 0.000 claims 1
- 208000009304 Acute Kidney Injury Diseases 0.000 claims 1
- 206010061217 Infestation Diseases 0.000 claims 1
- MGJKQDOBUOMPEZ-UHFFFAOYSA-N N,N'-dimethylurea Chemical compound CNC(=O)NC MGJKQDOBUOMPEZ-UHFFFAOYSA-N 0.000 claims 1
- CAUJXTGSPUXZGB-UHFFFAOYSA-N N-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl)phenyl]-3-methylmorpholine-4-carboxamide Chemical compound ClC=1C=C2C(CN(CC2=C(C=1)Cl)C)C=1C=C(C=CC=1)NC(=O)N1C(COCC1)C CAUJXTGSPUXZGB-UHFFFAOYSA-N 0.000 claims 1
- 208000033626 Renal failure acute Diseases 0.000 claims 1
- 108091006649 SLC9A3 Proteins 0.000 claims 1
- 206010041235 Snoring Diseases 0.000 claims 1
- 102100030375 Sodium/hydrogen exchanger 3 Human genes 0.000 claims 1
- OTBKUBKQEMWWIQ-UHFFFAOYSA-N [3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]carbamic acid Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(NC(O)=O)=C1 OTBKUBKQEMWWIQ-UHFFFAOYSA-N 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 201000011040 acute kidney failure Diseases 0.000 claims 1
- 208000012998 acute renal failure Diseases 0.000 claims 1
- 230000004663 cell proliferation Effects 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000020832 chronic kidney disease Diseases 0.000 claims 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 claims 1
- AIMMVWOEOZMVMS-UHFFFAOYSA-N cyclopropanecarboxamide Chemical compound NC(=O)C1CC1 AIMMVWOEOZMVMS-UHFFFAOYSA-N 0.000 claims 1
- 244000078703 ectoparasite Species 0.000 claims 1
- DBANRTGNUMHLRG-UHFFFAOYSA-N ethyl n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]carbamate Chemical compound C1=CC(NC(=O)OCC)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 DBANRTGNUMHLRG-UHFFFAOYSA-N 0.000 claims 1
- 230000006870 function Effects 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 230000003871 intestinal function Effects 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 208000017169 kidney disease Diseases 0.000 claims 1
- 230000037356 lipid metabolism Effects 0.000 claims 1
- UJROOBBEEKKHHV-UHFFFAOYSA-N n-(2-methyl-4-phenyl-3,4-dihydro-1h-isoquinolin-8-yl)acetamide Chemical compound C12=CC=CC(NC(C)=O)=C2CN(C)CC1C1=CC=CC=C1 UJROOBBEEKKHHV-UHFFFAOYSA-N 0.000 claims 1
- PQJBBZQLGILTCY-UHFFFAOYSA-N n-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-2,2,2-trifluoroacetamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC=C1NC(=O)C(F)(F)F PQJBBZQLGILTCY-UHFFFAOYSA-N 0.000 claims 1
- KSLUOYSGQYULGE-UHFFFAOYSA-N n-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]cyclopropanecarboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC=C1NC(=O)C1CC1 KSLUOYSGQYULGE-UHFFFAOYSA-N 0.000 claims 1
- QYCIEWHIEXOVHY-UHFFFAOYSA-N n-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]morpholine-4-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC=C1NC(=O)N1CCOCC1 QYCIEWHIEXOVHY-UHFFFAOYSA-N 0.000 claims 1
- ZXPOUZGOCVQBQG-UHFFFAOYSA-N n-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]piperidine-1-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC=C1NC(=O)N1CCCCC1 ZXPOUZGOCVQBQG-UHFFFAOYSA-N 0.000 claims 1
- OUPVIWYVYDCUHE-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1-methylpiperidine-4-carboxamide Chemical compound C1CN(C)CCC1C(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 OUPVIWYVYDCUHE-UHFFFAOYSA-N 0.000 claims 1
- DWZLGLACSQQZIM-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1h-imidazole-5-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)C1=CNC=N1 DWZLGLACSQQZIM-UHFFFAOYSA-N 0.000 claims 1
- YCKZHOANTKUZJC-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1h-pyrazole-4-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)C=1C=NNC=1 YCKZHOANTKUZJC-UHFFFAOYSA-N 0.000 claims 1
- GIEKZBPGVQLUIX-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1h-pyrazole-5-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)C1=CC=NN1 GIEKZBPGVQLUIX-UHFFFAOYSA-N 0.000 claims 1
- BXNFDJJZNJIRJF-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1h-pyrrole-2-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)C1=CC=CN1 BXNFDJJZNJIRJF-UHFFFAOYSA-N 0.000 claims 1
- OCAWHLGPCPIRKD-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1h-pyrrole-3-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)C=1C=CNC=1 OCAWHLGPCPIRKD-UHFFFAOYSA-N 0.000 claims 1
- TXICIEJZRRWVEG-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-2,4-dimethylpiperazine-1-carboxamide Chemical compound CC1CN(C)CCN1C(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 TXICIEJZRRWVEG-UHFFFAOYSA-N 0.000 claims 1
- TUOZJQVVJVSIIK-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-2,5-dimethyl-1h-pyrrole-3-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)C=1C=C(C)NC=1C TUOZJQVVJVSIIK-UHFFFAOYSA-N 0.000 claims 1
- TWSOHKAQPCCPQG-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]cyclopentanecarboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)C1CCCC1 TWSOHKAQPCCPQG-UHFFFAOYSA-N 0.000 claims 1
- QVLLBNWMNYZNPX-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]formamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(NC=O)=C1 QVLLBNWMNYZNPX-UHFFFAOYSA-N 0.000 claims 1
- DPQHWDSAFGLDQW-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]methanesulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(NS(C)(=O)=O)=C1 DPQHWDSAFGLDQW-UHFFFAOYSA-N 0.000 claims 1
- ZSFJSAZZSWAKTE-UHFFFAOYSA-N n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NC(=O)C1CCCN1 ZSFJSAZZSWAKTE-UHFFFAOYSA-N 0.000 claims 1
- PGWIHCXZCUNLPM-UHFFFAOYSA-N n-[4-(2-methyl-6-methylsulfonyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]acetamide Chemical compound C12=CC(S(C)(=O)=O)=CC=C2CN(C)CC1C1=CC=C(NC(C)=O)C=C1 PGWIHCXZCUNLPM-UHFFFAOYSA-N 0.000 claims 1
- ILFOJCUIQBNKHS-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1,1,1-trifluoromethanesulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(NS(=O)(=O)C(F)(F)F)C=C1 ILFOJCUIQBNKHS-UHFFFAOYSA-N 0.000 claims 1
- HLEFLYRGRHBCEA-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-1h-pyrazole-5-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)C1=CC=NN1 HLEFLYRGRHBCEA-UHFFFAOYSA-N 0.000 claims 1
- OICDJAHTNXTNBG-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-2,5-dimethyl-1h-pyrrole-3-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)C=1C=C(C)NC=1C OICDJAHTNXTNBG-UHFFFAOYSA-N 0.000 claims 1
- TVYZDFMOBGEOGU-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-2-(dimethylamino)acetamide Chemical compound C1=CC(NC(=O)CN(C)C)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 TVYZDFMOBGEOGU-UHFFFAOYSA-N 0.000 claims 1
- DVIMTYQAOYHYLU-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-2-methylpyrrolidine-1-carboxamide Chemical compound CC1CCCN1C(=O)NC1=CC=C(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)C=C1 DVIMTYQAOYHYLU-UHFFFAOYSA-N 0.000 claims 1
- PEXPIKIHXPMOGZ-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3,5-dimethyl-1h-pyrazole-4-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)C=1C(C)=NNC=1C PEXPIKIHXPMOGZ-UHFFFAOYSA-N 0.000 claims 1
- LIDLKEQMWPVUCP-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-4-methylpiperazine-1-carboxamide Chemical compound C1CN(C)CCN1C(=O)NC1=CC=C(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)C=C1 LIDLKEQMWPVUCP-UHFFFAOYSA-N 0.000 claims 1
- VPAXEEVXNPILRD-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]pyridine-3-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)C1=CC=CN=C1 VPAXEEVXNPILRD-UHFFFAOYSA-N 0.000 claims 1
- CDAIUKMBWGTSFZ-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]pyrrolidine-1-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)N1CCCC1 CDAIUKMBWGTSFZ-UHFFFAOYSA-N 0.000 claims 1
- OCFFALPYWKANKE-UHFFFAOYSA-N n-[4-[8-chloro-6-(cyclopropylmethylamino)-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl]phenyl]acetamide Chemical compound C12=CC(NCC3CC3)=CC(Cl)=C2CN(C)CC1C1=CC=C(NC(C)=O)C=C1 OCFFALPYWKANKE-UHFFFAOYSA-N 0.000 claims 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- XXPANQJNYNUNES-UHFFFAOYSA-N nomifensine Chemical compound C12=CC=CC(N)=C2CN(C)CC1C1=CC=CC=C1 XXPANQJNYNUNES-UHFFFAOYSA-N 0.000 claims 1
- 210000001428 peripheral nervous system Anatomy 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- YOAVGGWPQOACQB-UHFFFAOYSA-N propan-2-yl n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]carbamate Chemical compound CC(C)OC(=O)NC1=CC=CC(C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 YOAVGGWPQOACQB-UHFFFAOYSA-N 0.000 claims 1
- LCDCPQHFCOBUEF-UHFFFAOYSA-N pyrrolidine-1-carboxamide Chemical compound NC(=O)N1CCCC1 LCDCPQHFCOBUEF-UHFFFAOYSA-N 0.000 claims 1
- 230000000241 respiratory effect Effects 0.000 claims 1
- 229960000581 salicylamide Drugs 0.000 claims 1
- 230000035939 shock Effects 0.000 claims 1
- 201000002859 sleep apnea Diseases 0.000 claims 1
- 229940124530 sulfonamide Drugs 0.000 claims 1
- 150000003456 sulfonamides Chemical class 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- SDPZIVSAFCAYMC-UHFFFAOYSA-N 1-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-ethylthiourea Chemical compound CCNC(=S)NC1=CC=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 SDPZIVSAFCAYMC-UHFFFAOYSA-N 0.000 description 1
- RTEVZCUIXXCDNH-UHFFFAOYSA-N 1-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-ethylurea Chemical compound CCNC(=O)NC1=CC=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 RTEVZCUIXXCDNH-UHFFFAOYSA-N 0.000 description 1
- IYPIAJKDKNPXNO-UHFFFAOYSA-N 1-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-3-ethylthiourea Chemical compound C1=CC(NC(=S)NCC)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 IYPIAJKDKNPXNO-UHFFFAOYSA-N 0.000 description 1
- RYPNUXKTTFMKFH-UHFFFAOYSA-N 5-bromo-n-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]thiophene-2-sulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=1)=CC=CC=1NS(=O)(=O)C1=CC=C(Br)S1 RYPNUXKTTFMKFH-UHFFFAOYSA-N 0.000 description 1
- WJLVVYJYMZFJET-UHFFFAOYSA-N n-[2-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]butanamide Chemical compound CCCC(=O)NC1=CC=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 WJLVVYJYMZFJET-UHFFFAOYSA-N 0.000 description 1
- IUECDQZCOVVBQU-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]-5-(trifluoromethyl)-1h-pyrazole-4-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)C1=CNN=C1C(F)(F)F IUECDQZCOVVBQU-UHFFFAOYSA-N 0.000 description 1
- WSLYLXWYZBZFCE-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]butanamide Chemical compound C1=CC(NC(=O)CCC)=CC=C1C1C2=CC(Cl)=CC(Cl)=C2CN(C)C1 WSLYLXWYZBZFCE-UHFFFAOYSA-N 0.000 description 1
- VLXQFBRCVJQJIT-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]cyclobutanecarboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)C1CCC1 VLXQFBRCVJQJIT-UHFFFAOYSA-N 0.000 description 1
- ISLGZVHVMGDHPE-UHFFFAOYSA-N n-[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]pyridine-4-carboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C(C=C1)=CC=C1NC(=O)C1=CC=NC=C1 ISLGZVHVMGDHPE-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10159714 | 2001-12-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200403711B true ZA200403711B (en) | 2005-06-09 |
Family
ID=7708117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200403711A ZA200403711B (en) | 2001-12-05 | 2004-05-14 | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same. |
Country Status (34)
| Country | Link |
|---|---|
| EP (1) | EP1453810B1 (zh) |
| JP (1) | JP4510457B2 (zh) |
| KR (1) | KR20050044724A (zh) |
| CN (1) | CN100497314C (zh) |
| AR (1) | AR037620A1 (zh) |
| AT (1) | ATE425968T1 (zh) |
| AU (1) | AU2002356689B2 (zh) |
| BR (1) | BR0214753A (zh) |
| CA (1) | CA2469385A1 (zh) |
| CO (1) | CO5580748A2 (zh) |
| DE (1) | DE50213372D1 (zh) |
| DK (1) | DK1453810T3 (zh) |
| EC (1) | ECSP045138A (zh) |
| ES (1) | ES2324528T3 (zh) |
| HK (1) | HK1072597A1 (zh) |
| HR (1) | HRP20040507A2 (zh) |
| HU (1) | HUP0600854A2 (zh) |
| IL (1) | IL162316A0 (zh) |
| MA (1) | MA27147A1 (zh) |
| MX (1) | MXPA04005343A (zh) |
| MY (1) | MY157371A (zh) |
| NO (1) | NO326650B1 (zh) |
| NZ (1) | NZ533322A (zh) |
| OA (1) | OA12740A (zh) |
| PE (1) | PE20030726A1 (zh) |
| PL (1) | PL369313A1 (zh) |
| PT (1) | PT1453810E (zh) |
| RS (1) | RS48004A (zh) |
| RU (1) | RU2298003C2 (zh) |
| TN (1) | TNSN04100A1 (zh) |
| TW (1) | TWI281860B (zh) |
| UA (1) | UA77042C2 (zh) |
| WO (1) | WO2003048129A1 (zh) |
| ZA (1) | ZA200403711B (zh) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10312963A1 (de) * | 2003-03-24 | 2004-10-07 | Aventis Pharma Deutschland Gmbh | Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
| TW200526626A (en) | 2003-09-13 | 2005-08-16 | Astrazeneca Ab | Chemical compounds |
| DE102004046492A1 (de) | 2004-09-23 | 2006-03-30 | Sanofi-Aventis Deutschland Gmbh | Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
| US20060111393A1 (en) * | 2004-11-22 | 2006-05-25 | Molino Bruce F | 4-Phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| DE102005001411A1 (de) * | 2005-01-12 | 2006-07-27 | Sanofi-Aventis Deutschland Gmbh | Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
| CN101163693B (zh) | 2005-02-18 | 2013-03-06 | 阿斯利康(瑞典)有限公司 | 抗菌哌啶衍生物 |
| EP1861393A2 (en) * | 2005-03-04 | 2007-12-05 | AstraZeneca AB | Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |
| DE102005044817A1 (de) * | 2005-09-20 | 2007-03-22 | Sanofi-Aventis Deutschland Gmbh | Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
| DE102006012545A1 (de) * | 2006-03-18 | 2007-09-27 | Sanofi-Aventis | Substituierte 2-Amino-4-phenyl-dihydrochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
| HUE036405T2 (hu) * | 2008-12-31 | 2018-07-30 | Ardelyx Inc | Vegyületek és módszerek az NHE-közvetített (Na+/H+ cserével mûködõ) antiport gátlására folyadékretencióval vagy túlzott sómennyiség jelenlétével és a gyomor-bél traktus zavaraival összefüggõ rendellenességek kezelésében |
| WO2018129556A1 (en) * | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| US10543207B2 (en) | 2008-12-31 | 2020-01-28 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| KR20120034644A (ko) | 2009-05-12 | 2012-04-12 | 알바니 몰레큘라 리써치, 인크. | 아릴, 헤테로아릴, 및 헤테로사이클 치환된 테트라하이드로이소퀴놀린 및 이의 용도 |
| US20150299131A1 (en) * | 2012-08-21 | 2015-10-22 | Ardelyx, Inc | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| SI2983667T1 (sl) | 2013-04-12 | 2019-09-30 | Ardelyx, Inc. | Spojine za vezavo NHE3 in metode za zaviranje transporta fosfata |
| CN103788084A (zh) * | 2014-03-02 | 2014-05-14 | 湖南华腾制药有限公司 | 四氢异喹啉衍生物及其合成方法 |
| RS58378B1 (sr) * | 2014-07-25 | 2019-04-30 | Taisho Pharmaceutical Co Ltd | Fenil tetrahidroizokvinolinsko jedinjenje supstituisano heteroarilom |
| JP6903923B2 (ja) * | 2016-01-22 | 2021-07-14 | 大正製薬株式会社 | ヘテロアリールで置換されたフェニルテトラヒドロイソキノリン化合物を有効成分として含有する医薬 |
| US11147884B2 (en) | 2017-01-09 | 2021-10-19 | Ardelyx, Inc. | Inhibitors of NHE-mediated antiport |
| EP3565808A1 (en) | 2017-01-09 | 2019-11-13 | Ardelyx, Inc. | Compounds useful for treating gastrointestinal tract disorders |
| TWI805137B (zh) * | 2020-12-18 | 2023-06-11 | 大陸商上海濟煜醫藥科技有限公司 | 苯并雜環取代四氫異喹啉類化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19951702A1 (de) * | 1999-10-27 | 2001-05-03 | Aventis Pharma Gmbh | Verwendung von 2-Amino-3,4-dihydro-chinazolinen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten |
| JP4907817B2 (ja) * | 1999-11-03 | 2012-04-04 | エーエムアール テクノロジー インコーポレイテッド | ノルエピネフリン、ドーパミンおよびセロトニンの再取り込みを遮断するための、４−フェニル置換テトラヒドロイソキノリン類およびその利用 |
| JP4907818B2 (ja) * | 1999-11-03 | 2012-04-04 | エーエムアール テクノロジー インコーポレイテッド | アリールおよびヘテロアリール置換テトラヒドロイソキノリン、ならびにノルエピネフリン、ドーパミンおよびセロトニンの再取り込みを阻止するためのそれらの使用 |
| EP1113007A1 (en) * | 1999-12-24 | 2001-07-04 | Pfizer Inc. | Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| DE10019062A1 (de) * | 2000-04-18 | 2001-10-25 | Merck Patent Gmbh | 2-Guanidino-4-aryl-chinazoline als NHE-3 Inhibitoren |
-
2002
- 2002-11-20 JP JP2003549321A patent/JP4510457B2/ja not_active Expired - Fee Related
- 2002-11-20 CN CNB028278879A patent/CN100497314C/zh not_active Expired - Fee Related
- 2002-11-20 CA CA002469385A patent/CA2469385A1/en not_active Abandoned
- 2002-11-20 ES ES02804183T patent/ES2324528T3/es not_active Expired - Lifetime
- 2002-11-20 KR KR1020047008697A patent/KR20050044724A/ko active IP Right Grant
- 2002-11-20 HU HU0600854A patent/HUP0600854A2/hu unknown
- 2002-11-20 RU RU2004120295/04A patent/RU2298003C2/ru not_active IP Right Cessation
- 2002-11-20 AU AU2002356689A patent/AU2002356689B2/en not_active Ceased
- 2002-11-20 AT AT02804183T patent/ATE425968T1/de not_active IP Right Cessation
- 2002-11-20 BR BR0214753-0A patent/BR0214753A/pt not_active IP Right Cessation
- 2002-11-20 UA UA20040705310A patent/UA77042C2/uk unknown
- 2002-11-20 DE DE50213372T patent/DE50213372D1/de not_active Expired - Lifetime
- 2002-11-20 WO PCT/EP2002/012990 patent/WO2003048129A1/de active Application Filing
- 2002-11-20 PL PL02369313A patent/PL369313A1/xx not_active Application Discontinuation
- 2002-11-20 IL IL16231602A patent/IL162316A0/xx unknown
- 2002-11-20 EP EP02804183A patent/EP1453810B1/de not_active Expired - Lifetime
- 2002-11-20 RS YU48004A patent/RS48004A/sr unknown
- 2002-11-20 MX MXPA04005343A patent/MXPA04005343A/es active IP Right Grant
- 2002-11-20 PT PT02804183T patent/PT1453810E/pt unknown
- 2002-11-20 DK DK02804183T patent/DK1453810T3/da active
- 2002-11-20 NZ NZ533322A patent/NZ533322A/en unknown
- 2002-11-20 OA OA1200400166A patent/OA12740A/en unknown
- 2002-11-26 PE PE2002001138A patent/PE20030726A1/es not_active Application Discontinuation
- 2002-12-03 TW TW091134977A patent/TWI281860B/zh not_active IP Right Cessation
- 2002-12-03 AR ARP020104667A patent/AR037620A1/es unknown
- 2002-12-04 MY MYPI20024565A patent/MY157371A/en unknown
-
2004
- 2004-05-14 ZA ZA200403711A patent/ZA200403711B/en unknown
- 2004-05-21 MA MA27693A patent/MA27147A1/fr unknown
- 2004-05-25 NO NO20042158A patent/NO326650B1/no not_active IP Right Cessation
- 2004-06-03 CO CO04052088A patent/CO5580748A2/es not_active Application Discontinuation
- 2004-06-04 HR HR20040507A patent/HRP20040507A2/hr not_active Application Discontinuation
- 2004-06-04 TN TNP2004000100A patent/TNSN04100A1/en unknown
- 2004-06-04 EC EC2004005138A patent/ECSP045138A/es unknown
-
2005
- 2005-06-22 HK HK05105174.2A patent/HK1072597A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200403711B (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same. | |
| RU2201927C2 (ru) | Амидиновые соединения и фармацевтическая композиция, обладающая фактор ха ингибирующим действием | |
| RU2002125860A (ru) | Новые производные циклического амида | |
| RU2354653C2 (ru) | Производные 1-(2-аминобензол)пиперазина, используемые в качестве ингибиторов поглощения глицина и предназначенные для лечения психоза | |
| CA2465207C (en) | Pyrazole-amides and -sulfonamides | |
| ES2612686T3 (es) | Derivados de quinoxalina | |
| CA2643055A1 (en) | Tetralines antagonists of the h-3 receptor | |
| AU2008272964A1 (en) | NMDA receptor antagonists for neuroprotection | |
| CA2539479C (en) | Isoquinoline potassium channel inhibitors | |
| CA2258247A1 (en) | Sulphonamide derivatives and their use in the treatment of cns disorders | |
| CA2507027A1 (en) | Isoquinoline compounds and medicinal use thereof | |
| US5246935A (en) | Piperazinyl derivatives and methods of treating central nervous system ailments relating to the 5-ht2 receptor system | |
| CA2908542A1 (en) | Novel compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same | |
| PT2516009E (pt) | Isoquinolinonas e quinazolinonas substituídas | |
| JP2006500348A5 (zh) | ||
| RU2011127232A (ru) | Апоптоз-индуцирующие средства для лечения рака и иммунных и аутоиммунных заболеваний | |
| WO2005105779A1 (en) | 3-heterocyclyl-4-phenyl-triazole derivatives as inhibitors of the vasopressin v1a receptor | |
| JP2005537313A5 (zh) | ||
| WO2006048209A1 (de) | Neue bradykinin-b1-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
| JPS61282367A (ja) | ２−チオもしくはオキソ−４−アリ−ルまたはヘテロシクロ−１，５（２ｈ）−ピリミジンジカルボン酸ジエステル類並びに３−アシル−５−ピリミジンカルボン酸類およびエステル類 | |
| MX2010012186A (es) | Antagonistas del receptor nmda para el tratamiento de transtornos neuropsiquitricos. | |
| NZ603724A (en) | Piperidine derivatives and their use for the treatment of metabolic disorders | |
| AU2008240804A1 (en) | Pyrrolidine derivatives as dual NK1/NK3 receptor antagonists | |
| JP2007535478A5 (zh) | ||
| US6620839B2 (en) | 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |